We are live on ! Find out more
PILL icon

Direxion Daily Pharmaceutical & Medical Bull 3X ETF

4 hedge funds and large institutions have $475K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,039% more capital invested

Capital invested by funds: $15.1K → $475K (+$460K)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more funds holding

Funds holding: 34 (+1)

3.62% more ownership

Funds ownership: 0.1%3.72% (+3.6%)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$226K +$242K +36,292 New
TRCT
2
Tower Research Capital (TRC)
New York
$196K +$210K +31,529 New
UBS Group
3
UBS Group
Switzerland
$46.9K +$44.4K +6,668 +771%
AA
4
AlphaMark Advisors
Kentucky
$6K
Morgan Stanley
5
Morgan Stanley
New York
-$11 -1 Closed

PILL Hedge Fund Activity: Q2 2024 in Review

4 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2024, worth a combined $475K — up 3,039% from $15.1K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PILL positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $242K. The largest seller was Morgan Stanley, exiting entirely with an estimated $11 sold.

  • 4 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2024, up from 3 in Q1 2024.
  • Funds reported $475K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2024, up 3,039% quarter-over-quarter.
  • 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2024 and 1 closed out, a net change of +1 holder.
  • The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2024 was Susquehanna International Group, an estimated $242K added.
  • The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q2 2024 was Morgan Stanley, an estimated $11 sold.

Based on aggregated 13F filings for Q2 2024.